艾昆纬-将临床试验扩展到新界_探索成功的关键（英）-2025_12页_1mb

Summary of "Expanding Clinical Trials into New Territories: Exploring the Keys to Success"

Background and Opportunity

The white paper explores the growing trend of expanding clinical trials to new geographical regions, highlighting opportunities such as patient diversity, operational efficiency, and cost advantages. It emphasizes that success hinges on thorough preparation, local expertise, and collaboration with experienced Contract Research Organizations (CROs). Modern tools and technologies enable streamlined execution, while regulatory harmonization supports global research.

Key Drivers for Expansion

• Patient Recruitment and Diversity: Accessing broader patient populations accelerates enrollment and enhances data diversity, crucial for developing targeted treatments.
• Regulatory Flexibility: Faster approvals and reduced costs in countries with favorable regulatory environments.
• Cost Efficiency: Achieving operational savings through optimized site management and economies of scale.
• Access to Untapped Markets: Reaching new markets for commercial gains and scientific advancement.
• Technological Advancements: AI-driven enrollment modeling, risk-based monitoring, and digital tools improve efficiency and data quality.
• Regulatory Harmonization: Aligning global standards, as seen in EU initiatives, to simplify processes and facilitate multi-country trials.

Matching Trials to Countries

Careful scrutiny of factors like local infrastructure, healthcare systems, and cultural norms is essential. This includes assessing regulatory frameworks, patient demographics, and supply chain logistics. Data-driven forecasting and site intelligence help mitigate risks and ensure timely recruitment.

Balancing FSO and FSP Solutions

Smaller sponsors may benefit from full-service (FSO) offerings for comprehensive support. Larger organizations can leverage functional service provision (FSP) for agile, modular solutions that address gaps in their capabilities. Effective integration of roles, functions, and processes is key.

Critical Success Factors

• Infrastructure Assessment: Evaluating connectivity, transportation, sites, and vendors to support trial operations.
• Enrollment and Recruitment: Using tailored strategies, community engagement, and technology to overcome cultural barriers.
• Logistics and Supply Chain: Ensuring smooth import of trial supplies, waste disposal, and compliance with local regulations.
• Finances and Contracts: Managing payments, tax regulations, and legal compliance to avoid delays.
• Patient, Site, and Data Management: Implementing localized strategies to retain patients, support sites, and ensure data privacy and quality.

Conclusion

Expanding clinical trials abroad requires innovation, collaboration, and meticulous planning to access new markets quickly and cost-effectively. IQVIA advocates for partnerships with CROs offering local expertise and global reach, emphasizing that success demands a balance of technology, regulatory knowledge, and cultural sensitivity to minimize risks and achieve robust outcomes.